San Bruno, CA, United States of America

Daniela Keilberg

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Second Genome, Inc.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniela Keilberg. Retrieved from https://idiyas.com/inventor/daniela-keilberg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Therapeutic Proteins by Daniela Keilberg

Introduction

Daniela Keilberg is an accomplished inventor based in San Bruno, CA (US). She has made significant contributions to the field of therapeutic proteins, particularly in the treatment of epithelial barrier function disorders. Her work is vital for addressing various human diseases, especially those related to gastrointestinal health.

Latest Patents

Keilberg holds a patent for "Proteins for the treatment of epithelial barrier function disorders." This patent discloses therapeutic proteins and pharmaceutical compositions that are useful in treating human gastrointestinal inflammatory diseases. The therapeutic proteins are particularly effective for conditions associated with decreased epithelial cell barrier function or integrity. This includes inflammatory bowel diseases such as Crohn's disease and ulcerative colitis.

Career Highlights

Keilberg is currently associated with Second Genome, Inc., where she continues to innovate in the field of biotechnology. Her research focuses on developing solutions that enhance the treatment of gastrointestinal conditions, thereby improving patient outcomes.

Collaborations

Some of her notable coworkers include Cristina N Butterfield and Andrew Whitman Goodyear. Their collaborative efforts contribute to the advancement of therapeutic strategies in the biotechnology sector.

Conclusion

Daniela Keilberg's work in therapeutic proteins represents a significant advancement in the treatment of gastrointestinal diseases. Her innovative approach and dedication to research continue to pave the way for new therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…